Phase 1 Retroperitoneal Sarcoma Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma
Retroperitoneal Sarcoma
University of Washington18 enrolled1 locationNCT06025747
Recruiting
Phase 1Phase 2
Proton or Photon RT for Retroperitoneal Sarcomas
Retroperitoneal Sarcoma
Massachusetts General Hospital80 enrolled10 locationsNCT01659203
Recruiting
Phase 1Phase 2
Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma
Retroperitoneal Sarcoma
Northwestern University28 enrolled1 locationNCT06327477
Recruiting
Phase 1
Short Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery
Retroperitoneal Sarcoma
Brigham and Women's Hospital6 enrolled1 locationNCT06812052